{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:56:06Z","timestamp":1788580566010,"version":"build-2803163510"},"reference-count":38,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10,1]]},"abstract":"<jats:p>OBJECTIVE. Children &amp;lt;5 years old are at increased risk of miliary\/meningeal tuberculosis, but the immunologic factors that place them at risk are unknown. BCG vaccine protects against miliary\/meningeal tuberculosis, but the mechanism of protection is unknown. We assessed for abnormalities in immune response associated with miliary\/meningeal or pulmonary tuberculosis in young children.<\/jats:p><jats:p>PATIENTS AND METHODS. We conducted a case-control study among HIV-seronegative Brazilian children who were &amp;lt;5 years old. Case subjects had previous culture-confirmed or clinical miliary\/meningeal tuberculosis. There were 2 sets of control subjects: those with culture-confirmed pulmonary tuberculosis and purified protein derivative\u2013positive household contacts. All of the children had completed treatment. Peripheral blood mononuclear cells were stimulated (phytohemagglutinin, phytohemagglutinin + interleukin 12, lipopolysaccharide, lipopolysaccharide + interferon-\u03b3, and purified protein derivative), and cytokine responses (interleukin 1\u03b2, interleukin-4, interleukin-6, interleukin-8, interleukin 10, interleukin 12, interferon-\u03b3, tumor necrosis factor-\u03b1, and monocyte chemoattractant protein 1) were quantified by bead-based assay. Median cytokine responses were compared by the Kruskal-Wallis test. Multivariate analysis of variance accounted for multiple comparisons.<\/jats:p><jats:p>RESULTS. There were 18 case subjects with miliary\/meningeal tuberculosis, 28 pulmonary control subjects, and 29 purified protein derivative\u2013positive control subjects. The median age was 4.2 years. There was no difference in case and control subjects by age, gender, race, BMI, or median CD4 count. Twelve (67%) of 18 case subjects, 26 (93%) of 28 pulmonary control subjects, and 28 (97%) of 29 purified protein derivative\u2013positive subjects had received BCG vaccine. No cytokine defects were identified in case subjects with miliary\/meningeal tuberculosis compared with either set of control subjects. Pulmonary control subjects had uniformly higher monocyte chemoattractant protein 1 levels than case subjects with miliary\/meningeal tuberculosis and purified protein derivative\u2013positive control subjects, both at rest and with lipopolysaccharide, lipopolysaccharide + interferon-\u03b3, and purified protein derivative stimulation. Pulmonary control subjects did not have a higher frequency of allele G in the \u22122518 monocyte chemoattractant protein 1 promoter polymorphism. Case subjects with miliary\/meningeal tuberculosis who had received BCG vaccine (n = 12) had lower stimulated interleukin 8 production than children who did not receive BCG vaccine (n = 6).<\/jats:p><jats:p>CONCLUSIONS. Children with previous miliary\/meningeal tuberculosis did not have a major defect in the cytokine pathways studied. Increased monocyte chemoattractant protein 1 levels were associated with pulmonary disease, occurred despite BCG vaccination, and were not associated with a polymorphism in the monocyte chemoattractant protein 1 promoter.<\/jats:p>","DOI":"10.1542\/peds.2006-3150","type":"journal-article","created":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T17:11:46Z","timestamp":1191258706000},"page":"e912-e921","source":"Crossref","is-referenced-by-count":15,"title":["Immune Function in Young Children With Previous Pulmonary or Miliary\/Meningeal Tuberculosis and Impact of BCG Vaccination"],"prefix":"10.1542","volume":"120","author":[{"given":"Timothy R.","family":"Sterling","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezinha","family":"Martire","sequence":"additional","affiliation":[{"name":"Academic Tuberculosis Program, Clementino Fraga Filho University Hospital"},{"name":"Division of Pediatric Pneumology, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Silva","family":"de Almeida","sequence":"additional","affiliation":[{"name":"Academic Tuberculosis Program, Clementino Fraga Filho University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Alves","family":"Moreira","sequence":"additional","affiliation":[{"name":"Academic Tuberculosis Program, Clementino Fraga Filho University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Elloumi","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica P.V.","family":"Torres","sequence":"additional","affiliation":[{"name":"Academic Tuberculosis Program, Clementino Fraga Filho University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemax Couto","family":"Sant'Anna","sequence":"additional","affiliation":[{"name":"Martaga\u0303o Gesteira Pediatric Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Calazans","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital San Sebastian, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldo","family":"Paraguassu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurosurgery, Hospital Sao Goncalo, Sao Goncalo, Brazil"},{"name":"Department of Pediatric Neurosurgery, Hospital Municipal Jesus, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tebeb","family":"Gebretsadik","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Shintani","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afranio","family":"Kritski","sequence":"additional","affiliation":[{"name":"Academic Tuberculosis Program, Clementino Fraga Filho University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Roberto Lapa","family":"e Silva","sequence":"additional","affiliation":[{"name":"Academic Tuberculosis Program, Clementino Fraga Filho University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2007,10,1]]},"reference":[{"key":"2021120902302978400_R1","doi-asserted-by":"crossref","unstructured":"Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol.\u20081974;99:131\u2013138","DOI":"10.1093\/oxfordjournals.aje.a121593"},{"key":"2021120902302978400_R2","unstructured":"Gonzalez OY, Adams G, Teeter LD, Bui TT, Musser JM, Graviss EA. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis.\u20082003;7:1178\u20131185"},{"key":"2021120902302978400_R3","doi-asserted-by":"crossref","unstructured":"Ong A, Creasman J, Hopewell PC, et al. A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin Infect Dis.\u20082004;38:25\u201331","DOI":"10.1086\/380448"},{"key":"2021120902302978400_R4","doi-asserted-by":"crossref","unstructured":"Yang Z, Kong Y, Wilson F, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis.\u20082004;38:199\u2013205","DOI":"10.1086\/380644"},{"key":"2021120902302978400_R5","doi-asserted-by":"crossref","unstructured":"Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 counts in patients with human immunodeficiency infection. Am Rev Respir Dis.\u20081993;148:1292\u20131297","DOI":"10.1164\/ajrccm\/148.5.1292"},{"key":"2021120902302978400_R6","doi-asserted-by":"crossref","unstructured":"Wallgren A. The time-table of tuberculosis. Tubercle.\u20081948;29:245\u2013251","DOI":"10.1016\/S0041-3879(48)80033-4"},{"key":"2021120902302978400_R7","doi-asserted-by":"crossref","unstructured":"Rieder HL, Snider DE Jr, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis.\u20081990;141:347\u2013351","DOI":"10.1164\/ajrccm\/141.2.347"},{"key":"2021120902302978400_R8","unstructured":"Lewinsohn DA, Gennaro ML, Scholvinck L, Lewinsohn DM. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis.\u20082004;8:658\u2013674"},{"key":"2021120902302978400_R9","doi-asserted-by":"crossref","unstructured":"van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev.\u20082002;15:294\u2013309","DOI":"10.1128\/CMR.15.2.294-309.2002"},{"key":"2021120902302978400_R10","doi-asserted-by":"crossref","unstructured":"Orme I. Adaptive immunity to mycobacteria. Curr Opin Microbiol.\u20082004;7:58\u201361","DOI":"10.1016\/j.mib.2003.11.002"},{"key":"2021120902302978400_R11","doi-asserted-by":"crossref","unstructured":"Lincoln EM, Sordillo SVR, Davies PA. Tuberculous meningitis in children. J Pediatr.\u20081960;57:807\u2013823","DOI":"10.1016\/S0022-3476(60)80132-1"},{"key":"2021120902302978400_R12","doi-asserted-by":"crossref","unstructured":"Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA.\u20081979;241:264\u2013268","DOI":"10.1001\/jama.241.3.264"},{"key":"2021120902302978400_R13","doi-asserted-by":"crossref","unstructured":"Hussey G, Chisolm T, Kibel M. Miliary tuberculosis in children: a review of 94 cases. Pediatr Infect Dis J.\u20081991;10:832\u2013836","DOI":"10.1097\/00006454-199111000-00008"},{"key":"2021120902302978400_R14","doi-asserted-by":"crossref","unstructured":"Sterling TR, Dorman SE, Chaisson RE, et al. HIV-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses. Clin Infect Dis.\u20082001;33:976\u2013982","DOI":"10.1086\/322670"},{"key":"2021120902302978400_R15","doi-asserted-by":"crossref","unstructured":"Antas PRZ, Ding L, Hackman J, et al. Decreased CD4+ lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis. J Allerg Clin Immunol.\u20082006;117:916\u2013923","DOI":"10.1016\/j.jaci.2006.01.042"},{"key":"2021120902302978400_R16","doi-asserted-by":"crossref","unstructured":"Feja K, Saiman L. Tuberculosis in children. Clin Chest Med.\u20082005;26:295\u2013312, vii","DOI":"10.1016\/j.ccm.2005.02.010"},{"key":"2021120902302978400_R17","doi-asserted-by":"crossref","unstructured":"Alcais A, Fieschi C, Abel L, Casanova JL. Tuberculosis in children and adults: two distinct genetic diseases. J Exp Med.\u20082005;202:1617\u20131621","DOI":"10.1084\/jem.20052302"},{"key":"2021120902302978400_R18","doi-asserted-by":"crossref","unstructured":"Starke JR. Tuberculosis in children. Semin Respir Crit Care Med.\u20082004;25:353\u2013364","DOI":"10.1055\/s-2004-829507"},{"key":"2021120902302978400_R19","doi-asserted-by":"crossref","unstructured":"Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol.\u20081993;22:1154\u20131158","DOI":"10.1093\/ije\/22.6.1154"},{"key":"2021120902302978400_R20","doi-asserted-by":"crossref","unstructured":"Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analysis of the published literature. Pediatrics.\u20081995;96:29\u201335","DOI":"10.1542\/peds.96.1.29"},{"key":"2021120902302978400_R21","doi-asserted-by":"crossref","unstructured":"Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA.\u20081994;271:698\u2013702","DOI":"10.1001\/jama.271.9.698"},{"key":"2021120902302978400_R22","doi-asserted-by":"crossref","unstructured":"Comstock GW. Field trials of tuberculosis vaccines: how could we have done them better. Control Clin Trials.\u20081994;15:247\u2013276","DOI":"10.1016\/0197-2456(94)90042-6"},{"key":"2021120902302978400_R23","doi-asserted-by":"crossref","unstructured":"ten Dam HG, Pio A. Pathogenesis of tuberculosis and effectiveness of BCG vaccination. Tubercle.\u20081982;63:225\u2013233","DOI":"10.1016\/S0041-3879(82)80036-6"},{"key":"2021120902302978400_R24","doi-asserted-by":"crossref","unstructured":"Aronson NE, Santosham M, Comstock GW, et al. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study. JAMA.\u20082004;291:2086\u20132091","DOI":"10.1001\/jama.291.17.2086"},{"key":"2021120902302978400_R25","doi-asserted-by":"crossref","unstructured":"Sutherland I, Lindgren I. The protective effect of BCG vaccination as indicated by autopsy studies. Tubercle.\u20081979;60:225\u2013231","DOI":"10.1016\/0041-3879(79)90003-5"},{"key":"2021120902302978400_R26","doi-asserted-by":"crossref","unstructured":"Soysal A, Millington KA, Bakir M, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet.\u20082005;366:1443\u20131451","DOI":"10.1016\/S0140-6736(05)67534-4"},{"key":"2021120902302978400_R27","doi-asserted-by":"crossref","unstructured":"Hasan Z, Zaidi I, Jamil B, Khan MA, Kanji A, Hussain R. Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunol.\u20082005;6:14","DOI":"10.1186\/1471-2172-6-14"},{"key":"2021120902302978400_R28","doi-asserted-by":"crossref","unstructured":"Flores-Villanueva PO, Ruiz-Morales JA, Song CH, et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med.\u20082005;202:1649\u20131658","DOI":"10.1084\/jem.20050126"},{"key":"2021120902302978400_R29","doi-asserted-by":"crossref","unstructured":"Lopez-Maderuelo D, Arnalich F, Serantes R, et al. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med.\u20082003;167:970\u2013975","DOI":"10.1164\/rccm.200205-438BC"},{"key":"2021120902302978400_R30","unstructured":"Cooley WW, Lohnes PR. Multivariate Data Analysis. New York, NY: John Wiley & Sons; 1971"},{"key":"2021120902302978400_R31","doi-asserted-by":"crossref","unstructured":"Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med.\u20081994;330:1703\u20131709","DOI":"10.1056\/NEJM199406163302402"},{"key":"2021120902302978400_R32","doi-asserted-by":"crossref","unstructured":"Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med.\u20081994;330:1710\u20131716","DOI":"10.1056\/NEJM199406163302403"},{"key":"2021120902302978400_R33","doi-asserted-by":"crossref","unstructured":"Bishai WR, Graham NMH, Harrington S, et al. Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA.\u20081998;280:1679\u20131684","DOI":"10.1001\/jama.280.19.1679"},{"key":"2021120902302978400_R34","doi-asserted-by":"crossref","unstructured":"Jasmer RM, Hahn JA, Small PM, et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991\u20131997. Ann Intern Med.\u20081999;130:971\u2013978","DOI":"10.7326\/0003-4819-130-12-199906150-00004"},{"key":"2021120902302978400_R35","doi-asserted-by":"crossref","unstructured":"Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev.\u20082005;203:38\u201347","DOI":"10.1111\/j.0105-2896.2005.00227.x"},{"key":"2021120902302978400_R36","doi-asserted-by":"crossref","unstructured":"Simmons CP, Thwaites GE, Quyen NT, et al. Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome. J Immunol.\u20082006;176:2007\u20132014","DOI":"10.4049\/jimmunol.176.3.2007"},{"key":"2021120902302978400_R37","doi-asserted-by":"crossref","unstructured":"Simmons CP, Thwaites GE, Quyen NT, et al. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses. J Immunol.\u20082005;175:579\u2013590","DOI":"10.4049\/jimmunol.175.1.579"},{"key":"2021120902302978400_R38","doi-asserted-by":"crossref","unstructured":"Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis.\u20082005;5:415\u2013430","DOI":"10.1016\/S1473-3099(05)70163-8"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/4\/e912\/1175977\/zpe0100700e912.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/4\/e912\/1175977\/zpe0100700e912.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T08:56:35Z","timestamp":1684054595000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/120\/4\/e912\/71273\/Immune-Function-in-Young-Children-With-Previous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,1]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2007,10,1]]},"published-print":{"date-parts":[[2007,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-3150","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,1]]}}}